Tandem Diabetes Care's GAAP loss for six months of 2021 was $1.036 million, down 40.5 times from $41.974 million in the prior year. Revenue increased 51.2% to $313.176 million compared to $207.162 million a year earlier.
Tandem Diabetes Care's GAAP loss for six months of 2021 was $1.036 million, down 40.5 times from $41.974 million in the prior year. Revenue increased 51.2% to $313.176 million compared to $207.162 million a year earlier. 
investor.tandemdiabetes.com
English (US) 